Contributions Timothy F. Simpson, MD, PharmD Impact of Socioeconomic Status on Long-Term Mortality after Percutaneous Coronary Intervention in a Diverse Urban Population—Coverage of CRT 2024 Timothy F. Simpson, MD, PharmD Angiographic Quantitative Flow Ratio-Guided Coronary Intervention: Two-Year Outcomes of the FAVOR III China Trial—Coverage of TCT 2022
